201 related articles for article (PubMed ID: 9091520)
1. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.
Lévy S; Ricard P; Lau CP; Lok NS; Camm AJ; Murgatroyd FD; Jordaens LJ; Kappenberger LJ; Brugada P; Ripley KL
J Am Coll Cardiol; 1997 Mar; 29(4):750-5. PubMed ID: 9091520
[TBL] [Abstract][Full Text] [Related]
2. Transvenous cardioversion of atrial fibrillation using low-energy shocks.
Socas AG; Ricard P; Taramasco V; Guenoun M; Lévy S
J Interv Card Electrophysiol; 1997 Sep; 1(2):125-9. PubMed ID: 9869960
[TBL] [Abstract][Full Text] [Related]
3. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.
Lok NS; Lau CP; Tse HF; Ayers GM
J Am Coll Cardiol; 1997 Nov; 30(5):1324-30. PubMed ID: 9350935
[TBL] [Abstract][Full Text] [Related]
4. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.
Lévy S; Ricard P; Gueunoun M; Yapo F; Trigano J; Mansouri C; Paganelli F
Circulation; 1997 Jul; 96(1):253-9. PubMed ID: 9236442
[TBL] [Abstract][Full Text] [Related]
5. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.
Murgatroyd FD; Slade AK; Sopher SM; Rowland E; Ward DE; Camm AJ
J Am Coll Cardiol; 1995 May; 25(6):1347-53. PubMed ID: 7722132
[TBL] [Abstract][Full Text] [Related]
7. Internal cardioversion of chronic atrial fibrillation in patients.
Neri R; Palermo P; Cesario AS; Baragli D; Amici E; Gambelli G
Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2237-42. PubMed ID: 9309749
[TBL] [Abstract][Full Text] [Related]
8. Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks.
Boriani G; Biffi M; Zannoli R; Branzi A; Magnani B
Int J Cardiol; 1999 Sep; 71(1):63-9. PubMed ID: 10522566
[TBL] [Abstract][Full Text] [Related]
9. Internal cardioversion of atrial fibrillation in sheep.
Cooper RA; Alferness CA; Smith WM; Ideker RE
Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects and clinical determinants of defibrillation threshold for transvenous atrial defibrillation using biatrial biphasic shocks in patients with chronic atrial fibrillation.
Lok NS; Lau CP; Ho DS; Tang YW
Pacing Clin Electrophysiol; 1997 Apr; 20(4 Pt 1):899-908. PubMed ID: 9127394
[TBL] [Abstract][Full Text] [Related]
11. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
12. Safety of transvenous atrial defibrillation: studies in the canine sterile pericarditis model.
Sokoloski MC; Ayers GM; Kumagai K; Khrestian CM; Niwano S; Waldo AL
Circulation; 1997 Aug; 96(4):1343-50. PubMed ID: 9286968
[TBL] [Abstract][Full Text] [Related]
13. [Cardioversion of atrial fibrillation with low energy internal electric shock].
Ricard P; Socas AG; Taramasco V; Guenoun M; Lévy S
Arch Mal Coeur Vaiss; 1997 Dec; 90(12):1605-10. PubMed ID: 9587440
[TBL] [Abstract][Full Text] [Related]
14. Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks.
Sopher SM; Murgatroyd FD; Slade AK; Blankoff I; Rowland E; Ward DE; Camm AJ
Heart; 1996 Jun; 75(6):635-8. PubMed ID: 8697172
[TBL] [Abstract][Full Text] [Related]
15. Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock.
Janardhan AH; Gutbrod SR; Li W; Lang D; Schuessler RB; Efimov IR
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):40-8. PubMed ID: 24076284
[TBL] [Abstract][Full Text] [Related]
16. Initial clinical experience with an implantable human atrial defibrillator.
Lau CP; Tse HF; Lok NS; Lee KL; Ho DS; Sopher M; Murgatroyd F; Camm AJ
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):220-5. PubMed ID: 9121994
[TBL] [Abstract][Full Text] [Related]
17. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk.
Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A
Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545
[TBL] [Abstract][Full Text] [Related]
18. Low energy conversion of atrial fibrillation in the sheep.
Powell AC; Garan H; McGovern BA; Fallon JT; Krishnan SC; Ruskin JN
J Am Coll Cardiol; 1992 Sep; 20(3):707-11. PubMed ID: 1512352
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations.
Saksena S; Prakash A; Mangeon L; Varanasi S; Kolettis T; Mathew P; De Groot P; Mehra R; Krol RB
Am J Cardiol; 1995 Nov; 76(12):913-21. PubMed ID: 7484831
[TBL] [Abstract][Full Text] [Related]
20. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
Heisel A; Jung J; Fries R; Stopp M; Sen S; Schieffer H; Ozbek C
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):65-71. PubMed ID: 9121973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
